N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy-Reference-Cited by-同舟云学术

N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy

Published:2017-09-13 Issue:4 Volume:44 Page:457-465
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Chi Gerald^ORCID,Januzzi James L.,Korjian Serge,Daaboul Yazan,Goldhaber Samuel Z.,Hernandez Adrian F.,Hull Russell D.,Gold Alex,Cohen Alexander T.,Harrington Robert A.,Gibson C. Michael

Funder

Portola Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/article/10.1007/s11239-017-1552-7/fulltext.html

Reference26 articles.

1. Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, Mensah GA, Norrving B, Shiue I, Ng M, Estep K, Cercy K, Murray CJ, Forouzanfar MH, Global Burden of Diseases I, Risk Factors S, Stroke Experts Writing G (2016) Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol 15:913–924. doi:10.1016/S1474-4422(16)30073-4

2. ClinicalTrials.gov. Venous thromboembolic Event (VTE) Prophylaxis in medically Ill patients (MAGELLAN). https://clinicaltrials.gov/ct2/show/NCT00571649

3. Gibson CM, Chi G, Halaby R, Korjian S, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Gold A, Bandman O, Harrington RA, Cohen AT, Investigators A (2016) Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically Ill patients: an APEX trial substudy (acute medically ill venous thromboembolism prevention with extended duration betrixaban). Circulation. doi:10.1161/CIRCULATIONAHA.116.025427

4. Marszalek J, Mehrsefat S, Chi G (2017) The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis. Expert Rev Hematol 10:667–684. doi:10.1080/17474086.2017.1343662

5. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. New Engl J Med 339:321–328. doi:10.1056/NEJM199807303390507

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis;European Journal of Heart Failure;2023-12

2. Association of NT-proBNP and 7-day mortality of patients with acute ischemic stroke in intensive care unit: a retrospective cohort study;2023-08-30

3. Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials;Canadian Journal of Cardiology;2023-02

4. Value of N-Terminal Pro-Brain Natriuretic Peptide for Em-bolic Events Risk Prediction in Patients with Atrial Fibril-lation; a Systematic Review and Meta-Analysis;ARCH ACAD EMERG MED;2023

5. Prevalence and incidence of stroke, white matter hyperintensities, and silent brain infarcts in patients with chronic heart failure: A systematic review, meta-analysis, and meta-regression;Frontiers in Cardiovascular Medicine;2022-09-15